Diagnosis and treatment of autoimmune hepatitis

Czaja, 1995, Autoimmune hepatitis: evolving concepts and treatment strategies, Dig Dis Sci, 40, 435, 10.1007/BF02065434 Czaja, 1993, Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis, Gastroenterology, 105, 1824, 10.1016/0016-5085(93)91081-R Czaja, 2000, Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis, Immunol Rev, 174, 250, 10.1034/j.1600-0528.2002.017401.x Czaja, 2001, Understanding the pathogenesis of autoimmune hepatitis, Am J Gastroenterol, 96, 1224, 10.1111/j.1572-0241.2001.03707.x Boberg, 1998, Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, Scand J Gastroenterol, 33, 99, 10.1080/00365529850166284 Milkiewicz, 1999, Recurrence of autoimmune hepatitis after liver transplantation, Transplantation, 68, 253, 10.1097/00007890-199907270-00016 Wiesner, 1998, Acute allograft rejection: incidence, risk factors, and impact on outcome, Hepatology, 28, 638, 10.1002/hep.510280306 Czaja, 1998, Immune phenotype of chronic liver disease, Dig Dis Sci, 43, 2149, 10.1023/A:1018836004279 Gregorio, 1997, Autoimmune hepatitis in childhood. A 20 year survey, Hepatology, 25, 541, 10.1002/hep.510250308 Fainboim, 1994, Chronic active autoimmune hepatitis in children. Strong association with a particular HLA DR6 (DRB1*1301) haplotype, Hum Immunol, 41, 146, 10.1016/0198-8859(94)90008-6 Seki, 1992, HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients, Gastroenterology, 103, 1041, 10.1016/0016-5085(92)90041-V Bittencourt, 1998, Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2, Am J Gastroenterol, 93, 1394, 10.1111/j.1572-0241.1998.1394a.x Gupta, 2001, Autoimmune hepatitis in the Indian subcontinent: 7 years experience, J Gastroenterol Hepatol, 16, 1144, 10.1046/j.1440-1746.2001.02602.x Lim, 2001, Autoimmune hepatitis in African Americans: presenting features and response to therapy, Am J Gastroenterol, 96, 3390, 10.1111/j.1572-0241.2001.05272.x Soloway, 1972, Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis, Gastroenterology, 63, 820, 10.1016/S0016-5085(19)33223-8 Mistilis, 1968, Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality, and survival, Australas Ann Med, 17, 214, 10.1111/imj.1968.17.3.214 Murray-Lyon, 1973, Controlled trial of prednisone and azathioprine in active chronic hepatitis, Lancet, 1, 735, 10.1016/S0140-6736(73)92125-9 Schalm, 1977, Severe chronic active liver disease. Prognostic significance of initial morphologic patterns, Am J Dig Dis, 22, 973, 10.1007/BF01076196 DeGroote, 1978, Long-term follow-up of chronic active hepatitis of moderate severity, Gut, 19, 510, 10.1136/gut.19.6.510 Czaja, 1983, Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology, Gastroenterology, 85, 713, 10.1016/0016-5085(83)90030-6 Crapper, 1986, “Acute” autoimmune hepatitis, Digestion, 34, 216, 10.1159/000199332 Amontree, 1989, Autoimmune chronic active hepatitis masquerading as acute hepatitis, J Clin Gastroenterol, 11, 303, 10.1097/00004836-198906000-00012 Nikias, 1994, The nature and prognostic implications of autoimmune hepatitis with an acute presentation, J Hepatol, 21, 866, 10.1016/S0168-8278(94)80251-3 Porta, 1990, Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure, J Ped Gastroenterol Nutrition, 11, 138, 10.1097/00005176-199007000-00027 Cook, 1971, Controlled prospective trial of corticosteroid therapy in active chronic hepatitis, Q J Med, 40, 159, 10.1093/oxfordjournals.qjmed.a067264 Sanchez-Urdazpal, 1992, Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis, Hepatology, 15, 215, 10.1002/hep.1840150208 González-Koch, 2001, Recurrent autoimmune hepatitis after orthotopic liver transplantation, Liver Transplantation, 4, 302, 10.1053/jlts.2001.21449 Ratziu, 1999, Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease, J Hepatol, 30, 131, 10.1016/S0168-8278(99)80017-8 Ahmed, 1997, Liver transplantation for autoimmune hepatitis: a 12-year experience, Transplantation Proceedings, 29, 496, 10.1016/S0041-1345(96)00223-0 Neuberger, 1984, Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting, Transplantation, 37, 363, 10.1097/00007890-198404000-00009 Wright, 1992, Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease, Transplantation, 53, 136, 10.1097/00007890-199201000-00027 Devlin, 1995, Recurrence of autoimmune hepatitis following liver transplantation, Liver Transplantation Surg, 1, 162, 10.1002/lt.500010305 Prados, 1998, Outcome of autoimmune hepatitis after liver transplantation, Transplantation, 66, 1645, 10.1097/00007890-199812270-00013 Gotz, 1999, Recurrence of autoimmune hepatitis after liver transplantation, Transplantation Proceedings, 31, 430, 10.1016/S0041-1345(98)01692-3 Birnbaum, 1997, Recurrence of autoimmune hepatitis in children after liver transplantation, J Pediatr Gastroenterol Nutr, 25, 20, 10.1097/00005176-199707000-00003 Johnson, 1993, Meeting Report. International Autoimmune Hepatitis Group, Hepatology, 18, 998, 10.1002/hep.1840180435 Alvarez, 1999, International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis, J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9 Frazer, 1985, The cellular infiltrate in the liver in autoimmune chronic active hepatitis: analysis with monoclonal antibodies, Liver, 5, 162, 10.1111/j.1600-0676.1985.tb00232.x Bach, 1992, The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis, Hepatology, 15, 572, 10.1002/hep.1840150403 Scheuer, 1992, The pathology of hepatitis C, Hepatology, 15, 567, 10.1002/hep.1840150402 Czaja, 1997, Histological findings in chronic hepatitis C with autoimmune features, Hepatology, 26, 459, 10.1002/hep.510260229 Czaja, 1981, Laboratory assessment of severe chronic active liver disease (CALD): correlation of serum transaminase and gamma globulin levels with histologic features, Gastroenterology, 80, 687, 10.1016/0016-5085(81)90126-8 Czaja, 1998, Frequency and nature of the variant syndromes of autoimmune liver disease, Hepatology, 28, 360, 10.1002/hep.510280210 Czaja, 2000, Autoimmune cholangitis within the spectrum of autoimmune liver disease, Hepatology, 31, 1231, 10.1053/jhep.2000.7878 Czaja, 2001, Autoimmune hepatitis with incidental histologic features of bile duct injury, Hepatology, 34, 659, 10.1053/jhep.2001.27562 Ben-Ari, 2001, Autoimmune hepatitis and its variant syndromes, Gut, 49, 589, 10.1136/gut.49.4.589 Czaja, 1998, Host- and disease-specific factors affecting steatosis in chronic hepatitis C, J Hepatol, 29, 198, 10.1016/S0168-8278(98)80004-4 Czaja, 1995, Autoantibodies, Bailliere's Clin Gastroenterol, 9, 723, 10.1016/0950-3528(95)90058-6 Czaja, 2001, Autoantibodies in liver disease, Gastroenterology, 120, 239, 10.1053/gast.2001.20223 Czaja, 1996, Validation of a scoring system for the diagnosis of autoimmune hepatitis, Dig Dis Sci, 41, 305, 10.1007/BF02093820 Bianchi, 1996, Impact of International Autoimmune Hepatitis Group scoring system in definition of autoimmune hepatitis. An Italian experience, Dig Dis Sci, 41, 166, 10.1007/BF02208600 Toda, 1997, Present status of autoimmune hepatitis in Japan- correlating the characteristics with international criteria in an area with a high rate of HCV infection, J Hepatol, 26, 1207, 10.1016/S0168-8278(97)80453-9 Miyakawa, 1997, Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis, J Gastroenterol, 32, 769, 10.1007/BF02936953 Dickson, 1997, The international autoimmune hepatitis score in chronic hepatitis C, J Viral Hep, 4, 121, 10.1111/j.1365-2893.1997.tb00214.x Boberg, 1996, Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis, Hepatology, 23, 1369, 10.1002/hep.510230612 Omagari, 2000, Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group, Intern Med, 39, 1008, 10.2169/internalmedicine.39.1008 Czaja, 1999, Behavior and significance of autoantibodies in type 1 autoimmune hepatitis, J Hepatol, 30, 394, 10.1016/S0168-8278(99)80096-8 Czaja, 1993, The nature and prognosis of severe cryptogenic chronic active hepatitis, Gastroenterology, 104, 1755, 10.1016/0016-5085(93)90656-W Czaja, 1993, Chronic active hepatitis: the challenge for a new nomenclature, Ann Intern Med, 119, 510, 10.7326/0003-4819-119-6-199309150-00011 Czaja, 1993, Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis, Gastroenterology, 105, 1522, 10.1016/0016-5085(93)90160-E Czaja, 1996, Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis, Dig Dis Sci, 41, 1733, 10.1007/BF02088738 Gregorio, 1997, Autoimmune hepatitis in childhood. A 20 year survey, Hepatology, 25, 541, 10.1002/hep.510250308 Gregorio, 2001, Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study, Hepatology, 33, 544, 10.1053/jhep.2001.22131 Czaja, 1994, Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis, Gastroenterology, 107, 200, 10.1016/0016-5085(94)90078-7 Homburger, 1998, Detection of antinuclear antibodies. Comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods, Arch Pathol Lab Med, 122, 993 Czaja, 1997, Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis, Dig Dis Sci, 42, 1688, 10.1023/A:1018809431189 Bernstein, 1984, Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis, Clin Exp Immunol, 55, 553 Chou, 1995, Specificity of antinuclear antibodies in primary biliary cirrhosis, Ann Rheum Dis, 54, 148, 10.1136/ard.54.2.148 Czaja, 1996, Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis, J Hepatol, 24, 52, 10.1016/S0168-8278(96)80186-3 Czaja, 2001, Shared genetic risk factors in autoimmune liver disease, Dig Dis Sci, 46, 140, 10.1023/A:1005670111068 Czaja, 1993, Genetic predispositions for the immunological features of chronic active hepatitis, Hepatology, 18, 816, 10.1002/hep.1840180411 Czaja, 1995, Immunologic features and HLA associations in chronic viral hepatitis, Gastroenterology, 108, 157, 10.1016/0016-5085(95)90020-9 Maddrey, 1977, Drug-induced chronic liver disease, Gastroenterology, 72, 1348, 10.1016/S0016-5085(77)80042-5 Seeff, 1981, Drug-induced chronic liver disease, with emphasis on chronic active hepatitis, Semin Liver Dis, 1, 104, 10.1055/s-2008-1040723 Hay, 1989, The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients, Hepatology, 9, 193, 10.1002/hep.1840090205 Kurki, 1984, Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease, Liver, 4, 134, 10.1111/j.1600-0676.1984.tb00918.x Konikoff, 1989, Antinuclear autoantibodies in chronic liver diseases, Hepato-gastroenterol, 36, 341 Whittingham, 1966, Smooth muscle autoantibody in “autoimmune” hepatitis, Gastroenterology, 51, 499, 10.1016/S0016-5085(19)34365-3 Bottazzo, 1976, Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence, J Clin Path, 29, 403, 10.1136/jcp.29.5.403 Toh, 1979, Smooth muscle autoantibody and autoantigens, Clin Exp Immunol, 38, 621 Czaja, 1996, Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis, Hepatology, 24, 1068, 10.1002/hep.510240515 Homberg, 1987, Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of “autoimmune” hepatitis, Hepatology, 7, 1333, 10.1002/hep.1840070626 Czaja, 1992, Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis, Gastroenterology, 103, 1290, 10.1016/0016-5085(92)91518-9 Manns, 1991, LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase, J Clin Invest, 88, 1370, 10.1172/JCI115443 Manns, 1990, Patients with type II autoimmune hepatitis express functionally intact cytochrome P-450 db1 that is inhibited by LKM-1 autoantibodies in vitro but not in vivo, Hepatology, 12, 127, 10.1002/hep.1840120120 Lohr, 1991, Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis, Clin Exp Immunol, 84, 297, 10.1111/j.1365-2249.1991.tb08164.x Todros, 1991, Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders, J Hepatol, 13, 128, 10.1016/0168-8278(91)90874-B Lunel, 1992, Liver/kidney microsome antibody type 1 and hepatitis C virus infection, Hepatology, 16, 630, 10.1002/hep.1840160304 Giostra, 1996, Low hepatitis C viremia in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis, J Hepatol, 25, 433, 10.1016/S0168-8278(96)80201-7 Mackie, 1994, Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus, Gastroenterology, 106, 1672, 10.1016/0016-5085(94)90426-X Reddy, 1995, Absence of anti-LKM1 in hepatitis C viral infection in the United States, J Viral Hepat, 2, 175, 10.1111/j.1365-2893.1995.tb00026.x Michitaka, 1994, Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2, Gastroenterology, 106, 1603, 10.1016/0016-5085(94)90417-0 Gerotto, 1994, Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies, J Hepatol, 21, 273, 10.1016/S0168-8278(05)80408-8 Yamamoto, 1993, Characterization of the anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera, Gastroenterology, 104, 1762, 10.1016/0016-5085(93)90657-X Czaja, 1997, Genetic distinctions between types 1 and 2 autoimmune hepatitis, Am J Gastroenterol, 92, 2197 Bittencourt, 1999, Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2, Am J Gastroenterol, 94, 1906, 10.1111/j.1572-0241.1999.01229.x Czaja, 1995, The validity and importance of subtypes of autoimmune hepatitis: a point of view, Am J Gastroenterol, 90, 1206 Targan, 1995, High-titer antineutrophil cytoplasmic antibodies in type 1 autoimmune hepatitis, Gastroenterology, 108, 1159, 10.1016/0016-5085(95)90215-5 Mulder, 1993, Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases, Hepatology, 17, 411, 10.1002/hep.1840170310 Zauli, 1997, Anti-neutrophil cytoplasmic antibodies in type 1 and type 2 autoimmune hepatitis, Hepatology, 25, 1105, 10.1002/hep.510250510 LaBrecque, 1999, Antineutrophil cytoplasmic antibody and chronic liver disease [abstract], Hepatology, 30, 428A Duerr, 1991, Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis, Gastroenterology, 100, 1385, 10.1016/0016-5085(91)70028-V Bansi, 1996, Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass, J Hepatol, 24, 581, 10.1016/S0168-8278(96)80144-9 Lidman, 1976, Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis, Clin Exp Immunol, 24, 266 Cancado, 1996, Heat serum inactivation as a mandatory procedure for antiactin antibody detection in cell culture, Hepatology, 23, 1098, 10.1002/hep.510230525 McFarlane, 1984, Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP), Clin Exp Immunol, 55, 347 Treichel, 1990, Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis, Hepatology, 11, 606, 10.1002/hep.1840110413 Poralla, 1991, The asialoglycoprotein receptor as target structure in autoimmune liver diseases, Semin Liver Dis, 11, 215, 10.1055/s-2008-1040439 McFarlane, 1984, Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis, Lancet, 2, 954, 10.1016/S0140-6736(84)91167-X Treichel, 1993, Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis, J Hepatol, 19, 55, 10.1016/S0168-8278(05)80176-X Czaja, 1996, Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis, Dig Dis Sci, 41, 1733, 10.1007/BF02088738 Baeres M Herkel J Czaja AJ Wies I Kanzler S Cancado EL Porta G Establishment of a standardized SLA/LP immunoassay: specificity for autoimmune hepatitis, worldwide occurrence and clinical characteristics Wies, 2000, Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis, Lancet, 355, 1510, 10.1016/S0140-6736(00)02166-8 Costa, 2000, Isolation and characterization of cDNA encoding the antigenic protein of the human tRNA(Ser)Sec complex recognized by autoantibodies from patients with type 1 autoimmune hepatitis, Clin Exp Immunol, 121, 364, 10.1046/j.1365-2249.2000.01280.x Kernebeck, 2001, A bioinformatical approach suggests the function of the autoimmune hepatitis target soluble liver antigen/liver pancreas, Hepatology, 34, 230, 10.1053/jhep.2001.26632 Kanzler, 1999, Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis, J Hepatol, 31, 635, 10.1016/S0168-8278(99)80342-0 Czaja, 2002, Antibodies to soluble liver antigen/liver pancreas and HLA risk factors in type 1 autoimmune hepatitis, Am J Gastroenterol, 97, 413, 10.1111/j.1572-0241.2002.05479.x Volkmann, 2001, Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically reacts with sera from patients with autoimmune hepatitis, Hepatology, 33, 591, 10.1053/jhep.2001.22218 Lapierre, 1999, Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis, Gastroenterology, 116, 643, 10.1016/S0016-5085(99)70186-1 Muratori, 2001, Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1, Hepatology, 34, 494, 10.1053/jhep.2001.27179 Pelli, 1998, Argininosuccinate lyase: a new autoantigen in liver disease, Clin Exp Immunol, 114, 455, 10.1046/j.1365-2249.1998.00754.x Abuaf, 1992, Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis, Hepatology, 16, 892, 10.1002/hep.1840160407 Martini, 1988, Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2, Hepatology, 8, 1662, 10.1002/hep.1840080632 Han, 1995, Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease, Hepatology, 21, 58 Muratori, 1998, Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis, Gut, 42, 721, 10.1136/gut.42.5.721 Manns, 1987, Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen, Lancet, 1, 292, 10.1016/S0140-6736(87)92024-1 Stechemesser, 1993, Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis, Hepatology, 18, 1, 10.1002/hep.1840180102 Donaldson, 1991, Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors, Hepatology, 13, 701, 10.1002/hep.1840130415 Strettell, 1997, Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis, Gastroenterology, 112, 2028, 10.1053/gast.1997.v112.pm9178696 Czaja, 1997, Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis, Hepatology, 25, 317, 10.1002/hep.510250211 Czaja, 1990, Clinical and prognostic implications of human leukocyte antigen B8 in corticosteroid-treated severe autoimmune chronic active hepatitis, Gastroenterology, 98, 1587, 10.1016/0016-5085(90)91095-N Czaja, 1993, Significance of HLA DR4 in type 1 autoimmune hepatitis, Gastroenterology, 105, 1502, 10.1016/0016-5085(93)90157-8 Clemente, 1997, Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1, J Clin Endocrinol Metab, 82, 1353 Clemente, 1998, Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1, Gastroenterology, 114, 324, 10.1016/S0016-5085(98)70484-6 Obermayer-Straub, 2001, Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, Gastroenterology, 121, 668, 10.1053/gast.2001.27103 Consortium, 1997, An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc finger domains, Nat Genet, 17, 399, 10.1038/ng1297-399 Aaltonen, 1994, An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type 1 assigned to chromosome 21, Nat Genet, 8, 83, 10.1038/ng0994-83 Nagamine, 1997, Positional cloning of the APECED gene, Nat Genet, 17, 393, 10.1038/ng1297-393 Roberts, 1996, Prognosis of histological cirrhosis in type 1 autoimmune hepatitis, Gastroenterology, 110, 848, 10.1053/gast.1996.v110.pm8608895 Koretz, 1980, Chronic active hepatitis, Who meets treatment criteria? Dig Dis Sci, 25, 695, 10.1007/BF01308329 Baggenstoss, 1972, Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution, Hum Pathol, 3, 183, 10.1016/S0046-8177(72)80072-8 Czaja, 1992, Frequency of antibody to hepatitis C virus in asymptomatic HBsAg negative chronic active hepatitis, J Hepatol, 14, 88, 10.1016/0168-8278(92)90135-C Summerskill, 1975, Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared, Gut, 16, 876, 10.1136/gut.16.11.876 Lewis, 1971, Prednisone side-effects and serum protein levels: a collaborative study, Lancet, 2, 778, 10.1016/S0140-6736(71)92738-3 Uribe, 1984, Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects, J Clin Gastroenterol, 6, 331 Stellon, 1985, Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy, Gastroenterology, 89, 1078, 10.1016/0016-5085(85)90212-4 Lebovics, 1985, Autoimmune chronic active hepatitis in postmenopausal women, Dig Dis Sci, 30, 824, 10.1007/BF01309511 Wang, 1989, Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis, Gastroenterology, 97, 1288, 10.1016/0016-5085(89)91701-0 Davis, 1984, Development and prognosis of histologic cirrhosis in corticosteroid-treated HBsAg-negative chronic active hepatitis, Gastroenterology, 87, 1222, 10.1016/0016-5085(84)90186-0 Czaja, 1984, Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis, Hepatology, 4, 622, 10.1002/hep.1840040409 Steven, 1979, Pregnancy in chronic active hepatitis, QJM, 48, 519 Lee, 1987, Pregnancy in chronic active hepatitis with cirrhosis, J Trop Med Hyg, 90, 245 Heneghan, 2001, Management and outcome of pregnancy in autoimmune hepatitis, Gut, 48, 97, 10.1136/gut.48.1.97 Rosenkrantz, 1967, Azathioprine (Imuran) and pregnancy, Am J Obstet Gynecol, 97, 387, 10.1016/0002-9378(67)90503-0 Varma, 1977, Pregnancy in cirrhotic and noncirrhotic portal hypertension, Obstet Gynecol, 50, 217 Maggiore, 1984, Treatment of autoimmune chronic active hepatitis in childhood, J Pediatr, 104, 839, 10.1016/S0022-3476(84)80477-1 Maggiore, 1993, Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents, J Pediatr Gastroenterol Nutr, 17, 376, 10.1097/00005176-199311000-00007 Roberts, 1995, Autoimmune hepatitis, Indian J Pediatr, 62, 525, 10.1007/BF02761871 Schalm, 1977, Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone, Gastroenterology, 72, 910, 10.1016/S0016-5085(77)80209-6 DePinho, 1984, Azathioprine and the liver. Evidence favoring idiosyncratic, mixed cholestatic-hepatocellular injury in humans, Gastroenterology, 86, 162, 10.1016/0016-5085(84)90603-6 Read, 1986, Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy, Ann Int Med, 104, 651, 10.7326/0003-4819-104-5-651 Katzka, 1986, Azathioprine and hepatic venocclusive disease in renal transplant patients, Gastroenterology, 90, 446, 10.1016/0016-5085(86)90947-9 Eland, 1999, Drug-associated acute pancreatitis: twenty-one years of spontaneous reporting in The Netherlands, Am J Gastroenterol, 94, 2417, 10.1111/j.1572-0241.1999.01367.x Tragnone, 1996, Acute pancreatitis after azathioprine treatment for ulcerative colitis, Ital J Gastroenterol, 28, 102 Lennard, 1989, Pharmacokinetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism, Clin Pharmacol Ther, 46, 149, 10.1038/clpt.1989.119 Ben Ari, 1995, Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis, J Hepatol, 23, 351 Lennard, 1998, Clinical implications of thiopurine methyltransferase-optimization of drug dosage and potential drug interactions, Therap Drug Monit, 20, 527, 10.1097/00007691-199810000-00014 Yates, 1997, Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance, Ann Int Med, 126, 608, 10.7326/0003-4819-126-8-199704150-00003 Heneghan, 2002, Current and novel immunosuppressive therapy for autoimmune hepatitis, Hepatology, 35, 7, 10.1053/jhep.2002.30991 Penn, 1979, Tumor incidence in allograft recipients, Transplant Proc, 11, 1047 Aguilar, 1997, Azathioprine-induced lymphoma manifesting as fulminant hepatic failure, Mayo Clin Proc, 72, 643, 10.1016/S0025-6196(11)63570-2 Wang, 1989, Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis, Hepatology, 10, 39, 10.1002/hep.1840100110 Wang, 1988, Hepatocellular cancer in corticosteroid-treated severe autoimmune chronic active hepatitis, Hepatology, 8, 1679, 10.1002/hep.1840080635 Park, 2000, Hepatocellular carcinoma in autoimmune hepatitis, Dig Dis Sci, 45, 1944, 10.1023/A:1005638500236 Ryder, 1995, Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus, Hepatology, 22, 718 Liberman, 1995, Effect of oral alendronate on bone mineral density and the incidence of fractures in portmenopausal osteoporosis, N Engl J Med, 333, 1437, 10.1056/NEJM199511303332201 Guanabens, 1997, Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years, Gastroenterology, 113, 219, 10.1016/S0016-5085(97)70098-2 Wolfhagen, 1997, Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study, J Hepatol, 26, 325, 10.1016/S0168-8278(97)80048-7 Yachha, 2001, Autoimmune liver disease in children, J Gastroenterol Hepatol, 16, 674, 10.1046/j.1440-1746.2001.02492.x Debray, 1999, Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis, J Pediatrics, 135, 111, 10.1016/S0022-3476(99)70339-2 Alvarez, 1999, Short-term cyclosporine induces a remission of autoimmune hepatitis in children, J Hepatol, 30, 222, 10.1016/S0168-8278(99)80065-8 Malekzadeh, 2001, Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis, Dig Dis Sci, 46, 1321, 10.1023/A:1010683817344 Czaja, 1987, Sustained remission following corticosteroid therapy of severe HBsAg-negative chronic active hepatitis, Gastroenterology, 92, 215, 10.1016/0016-5085(87)90862-6 Czaja, 2002, Sustained remission after corticosteroid therapy of type 1 autoimmune hepatitis: a retrospective analysis, Hepatology, 35, 890, 10.1053/jhep.2002.32485 Czaja, 1988, Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis, Gastroenterology, 95, 448, 10.1016/0016-5085(88)90503-3 Czaja, 1980, Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission, Gastroenterology, 78, 518, 10.1016/0016-5085(80)90866-5 Czaja, 1981, Corticosteroid-treated chronic active hepatitis in remission. Uncertain prognosis of chronic persistent hepatitis, N Engl J Med, 304, 5, 10.1056/NEJM198101013040102 Hegarty, 1983, Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis, Hepatology, 3, 685, 10.1002/hep.1840030510 Schalm, 1976, Failure of customary treatment in chronic active liver disease: causes and management, Ann Clin Res, 8, 221 Davis, 1986, Chronic Active Hepatitis. The Mayo Clinic Experience, 269 Czaja, 1990, Low dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis, Hepatology, 11, 1044, 10.1002/hep.1840110621 Runyon, 1987, Exquisite sensitivity to small decrements in corticosteroid dose in autoimmune chronic active hepatitis, J Clin Gastroenterol, 9, 541, 10.1097/00004836-198710000-00010 Stellon, 1988, Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal, Hepatology, 8, 781, 10.1002/hep.1840080414 Johnson, 1995, Azathioprine for long-term maintenance of remission in autoimmune hepatitis, N Engl J Med, 333, 958, 10.1056/NEJM199510123331502 Czaja, 1993, Oral pulse prednisone therapy after relapse of severe autoimmune chronic active hepatitis. A prospective randomized treatment trial evaluating clinical, biochemical, and lymphocyte subset responses, J Hepatol, 17, 180, 10.1016/S0168-8278(05)80035-2 Czaja, 1999, Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial, Hepatology, 30, 1381, 10.1002/hep.510300603 Czaja, 2000, Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis, Gastroenterology, 119, 1312, 10.1053/gast.2000.0010000001 Mistilis, 1985, Cyclosporin, a new treatment for autoimmune chronic active hepatitis, Med J Austr, 143, 463, 10.5694/j.1326-5377.1985.tb123140.x Hyams, 1987, Cyclosporine treatment of autoimmune chronic active hepatitis, Gastroenterology, 93, 890, 10.1016/0016-5085(87)90454-9 Person, 1993, A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis, J Clin Gastroenterol, 17, 317, 10.1097/00004836-199312000-00012 Sherman, 1994, Cyclosporine in the management of corticosteroid-resistant type 1 autoimmune chronic active hepatitis, J Hepatol, 21, 1040, 10.1016/S0168-8278(05)80615-4 Jackson, 1995, Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis, Gut, 36, 459, 10.1136/gut.36.3.459 Fernandes, 1999, Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis, Am J Gastroenterol, 94, 241, 10.1111/j.1572-0241.1999.00807.x Pratt, 1996, The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine, Gastroenterology, 110, 271, 10.1053/gast.1996.v110.pm8536867 Burak, 1998, Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate, J Hepatol, 29, 990, 10.1016/S0168-8278(98)80128-1 Kanzler, 1997, Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases, Z Gastroenterol, 35, 571 Richardson, 2000, Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis patients resistant to or intolerant of azathioprine, J Hepatol, 33, 371, 10.1016/S0168-8278(00)80271-8 Seaberg, 1999, Clinical Transplants 1998, 17 Hurtova, 2001, Successful tacrolimus therapy for severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient, Liver Transpl, 7, 556, 10.1053/jlts.2001.24638 Jones, 1999, Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis, Hepatology, 30, 53, 10.1002/hep.510300103 Heneghan, 2001, Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults, Hepatology, 34, 464, 10.1053/jhep.2001.26756 Kerkar, 1998, De-novo autoimmune hepatitis after liver transplantation, Lancet, 353, 409, 10.1016/S0140-6736(97)06478-7 Spada, 2001, A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis, Transplantation Proc, 33, 1747, 10.1016/S0041-1345(00)02826-8 Gupta, 2001, De novo hepatitis with autoimmune antibodies and atypical histology. A rare cause of late graft dysfunction after pediatric liver transplantation, Transplantation, 71, 664, 10.1097/00007890-200103150-00016 Salcedo, 2002, Response to steroids in de novo autoimmune hepatitis after transplantation, Hepatology, 35, 349, 10.1053/jhep.2002.31167 Czaja, 2002, Autoimmune hepatitis after liver transplantation and other lessons of self intolerance, Liver Transplantation, 8, 505, 10.1053/jlts.2002.33485